Mike Kratky
Stock Analyst at Leerink Partners
(4.47)
# 1,245
Out of 5,116 analysts
285
Total ratings
48.2%
Success rate
13.4%
Average return
Main Sectors:
Stocks Rated by Mike Kratky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EW Edwards Lifesciences | Reiterated: Buy | $101 → $112 | $102.14 | +9.65% | 35 | Nov 5, 2026 | |
| PODD Insulet | Reiterated: Hold | $143 → $167 | $146.51 | +13.99% | 18 | Nov 5, 2026 | |
| PRCT PROCEPT BioRobotics | Reiterated: Hold | $20 → $22 | $20.62 | +6.69% | 21 | Nov 5, 2026 | |
| SYK Stryker | Reiterated: Buy | $353 → $340 | $325.87 | +4.34% | 3 | Nov 2, 2026 | |
| AXGN Axogen | Reiterated: Buy | $52 → $56 | $50.02 | +11.96% | 19 | Oct 29, 2026 | |
| BSX Boston Scientific | Reiterated: Buy | $55 → $50 | $42.75 | +16.96% | 11 | Oct 29, 2026 | |
| ISRG Intuitive Surgical | Reiterated: Buy | $473 → $503 | $452.80 | +11.09% | 25 | Oct 21, 2026 | |
| ZBH Zimmer Biomet Holdings | Rated: Hold | $101 → $97 | $105.59 | -8.14% | 2 | Oct 12, 2026 | |
| BBNX Beta Bionics | Reiterated: Buy | $28 → $27 | $15.70 | +71.97% | 6 | Sep 17, 2026 | |
| MDT Medtronic | Reiterated: Buy | n/a | $101.80 | - | 8 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $327 → $374 | $319.21 | +17.16% | 8 | Jan 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $136 | $109.93 | n/a | 4 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $46.96 | n/a | 1 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $101 → $84 | $79.41 | n/a | 21 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $96 | $63.98 | n/a | 28 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $29 | $16.91 | n/a | 17 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $48 | $54.62 | n/a | 18 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $18 | $12.50 | n/a | 16 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $276.22 | n/a | 1 | Apr 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1,354.00 | n/a | 1 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 → $46 | $0.8097 | n/a | 11 | Sep 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $31 | $131.73 | n/a | 10 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $28.49 | n/a | 1 | Aug 15, 2022 |
Edwards Lifesciences
Nov 5, 2026
Reiterated: Buy
Price Target: $101 → $112
Current: $102.14
Upside: +9.65%
Insulet
Nov 5, 2026
Reiterated: Hold
Price Target: $143 → $167
Current: $146.51
Upside: +13.99%
PROCEPT BioRobotics
Nov 5, 2026
Reiterated: Hold
Price Target: $20 → $22
Current: $20.62
Upside: +6.69%
Stryker
Nov 2, 2026
Reiterated: Buy
Price Target: $353 → $340
Current: $325.87
Upside: +4.34%
Axogen
Oct 29, 2026
Reiterated: Buy
Price Target: $52 → $56
Current: $50.02
Upside: +11.96%
Boston Scientific
Oct 29, 2026
Reiterated: Buy
Price Target: $55 → $50
Current: $42.75
Upside: +16.96%
Intuitive Surgical
Oct 21, 2026
Reiterated: Buy
Price Target: $473 → $503
Current: $452.80
Upside: +11.09%
Zimmer Biomet Holdings
Oct 12, 2026
Rated: Hold
Price Target: $101 → $97
Current: $105.59
Upside: -8.14%
Beta Bionics
Sep 17, 2026
Reiterated: Buy
Price Target: $28 → $27
Current: $15.70
Upside: +71.97%
Medtronic
Jul 10, 2026
Reiterated: Buy
Price Target: n/a
Current: $101.80
Upside: -
Jan 15, 2026
Downgraded: Hold
Price Target: $327 → $374
Current: $319.21
Upside: +17.16%
Oct 16, 2025
Reiterated: Hold
Price Target: $136
Current: $109.93
Upside: n/a
Oct 14, 2025
Reiterated: Buy
Price Target: n/a
Current: $46.96
Upside: n/a
Oct 14, 2025
Reiterated: Buy
Price Target: $101 → $84
Current: $79.41
Upside: n/a
Oct 14, 2025
Reiterated: Hold
Price Target: $96
Current: $63.98
Upside: n/a
Oct 14, 2025
Reiterated: Buy
Price Target: $32 → $29
Current: $16.91
Upside: n/a
Oct 14, 2025
Reiterated: Buy
Price Target: $50 → $48
Current: $54.62
Upside: n/a
Aug 13, 2025
Reiterated: Buy
Price Target: $17 → $18
Current: $12.50
Upside: n/a
Apr 5, 2024
Reiterated: Buy
Price Target: n/a
Current: $276.22
Upside: n/a
Oct 16, 2023
Reiterated: Buy
Price Target: n/a
Current: $1,354.00
Upside: n/a
Sep 26, 2023
Reiterated: Buy
Price Target: $45 → $46
Current: $0.8097
Upside: n/a
May 4, 2023
Reiterated: Hold
Price Target: $31
Current: $131.73
Upside: n/a
Aug 15, 2022
Reiterated: Buy
Price Target: $40
Current: $28.49
Upside: n/a